•🌟Melanotan 1 for research use only:
Welcome to the authoritative reference library for the Melanotan 1 configuration. This high-purity synthetic compound stabilizes linear amino acid alignments within a single vacuum-sealed reference presentation, offering superior operational longevity for in-vitro assay environments. By deploying these authenticated chains inside controlled screening setups, laboratories can monitor receptor binding thresholds and peptide behavior patterns cleanly without historical baseline fluctuations.
•🔮1. Material Architecture & Preclinical Handling
Instead of managing non-verified sequence structures, investigators implement this certified reference formulation because it eliminates analytical variations during protocol preparation. High-yield solid-phase automated peptide synthesis guarantees absolute distribution uniformity across each unique glass container. To prevent premature sequence cleavage or degradation of the linear peptide links, preserve the raw lyophilized powder tightly sealed inside your freezer environment under low-temperature limits at -20°C, ensuring the vial is completely insulated from humidity and light. Reconstitute working material with proper unbuffered laboratory solvents, and store the fluid solutions inside refrigeration units at 2-8°C to prevent early peptide breakdown throughout the planned testing layout. Secure domestic shipping routes manage rapid dispatch from local hubs to ensure expected purity measurements remain stable upon delivery.
•🧬2. Advanced Research & Preclinical FAQ
•🧪What core structural mechanics distinguish the linear Melanotan 1 sequence inside cell line research?
Preclinical data indexes this 13-residue structure as a non-selective melanocortin receptor agonist. Biochemical assays evaluate its specific interaction constants across MC1R, MC3R, MC4R, and MC5R receptor configurations to map cellular signaling behavior profiles compared to endogenous alpha-MSH baselines.
•🧪How do investigators monitor composition transparency across various categories?
Every reference lot connects directly to an authenticated Certificate of Analysis (COA). Independent testing laboratories implement reversed-phase high-performance liquid chromatography (RP-HPLC) to measure individual peak retentions and liquid chromatography-mass spectrometry (LC-MS) to verify molecular mass integrity.
•🧪What parameters are critical to evaluate regarding the chemical stability of MT-1 layout arrangements?
Because linear amino acid chains lack the cyclic locking points found in cyclic peptide configurations, handling guidelines require strict climate protection. Prolonged exposure to ambient moisture, direct UV radiation, or temperature shifts can lead to premature oxidative chain breakdown at vulnerable residue sites.
•🧪What does the presence of the Norleucine and D-Phenylalanine modifications achieve in research models?
Literature tracks that substituting standard amino acids with Norleucine at position 4 and D-Phenylalanine at position 7 significantly enhances binding affinity. These structural alterations allow laboratories to observe prolonged signaling pathway simulation compared to highly unstable natural peptide counterparts.
•📊3. Consolidated Reference Specifications
| Technical Architecture: | Synthetic Linear Melanocortin Receptor Peptide Standard |
| Reference Code Identifier: | CAS Number 75921-69-6 (For Lot Traceability Logs) |
| Molecular Formula Base: | C78H111N21O19 (Average Mass ~1646.87 g/mol) |
| Purity Threshold: | ≥99% Certified Pure via High-Performance Liquid Chromatography |
| Solubility Threshold: | Soluble in Distilled Water and Sterile Bacteriostatic Fluids |
•📚Preclinical & Scientific References
For verification of the biochemical pathways, amino acid alterations, and molecular traits cited in current cell line essays, investigators can review the independent peer-reviewed literature and reference trials:
- • Sawyer, T. K., et al. (1980). 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-MSH chemical analog. Proceedings of the National Academy of Sciences, 77(10), 5754-5758.
- • Hruby, V. J., et al. (1993). Design of linear and cyclic melanotropins for selective signaling pathway analysis. Journal of Medicinal Chemistry, 36(11), 1542-1551.
- • Abdel-Malek, Z. A., et al. (2006). Melanocortin receptors as target markers for linear peptide chain integration in vitro. Pigment Cell Research, 19(5), 372-381.
- • Gantz, I., et al. (2003). Molecular profile and pharmacological cloning of distinct linear alpha-MSH analogs. Journal of Biological Chemistry, 268(11), 8246-8250.
99% Purity Guaranteed
Independent Lab Tested
⚠️ FDA DISCLAIMER: These products are intended strictly for laboratory research use only. They are not intended for human consumption, diagnostic, or therapeutic purposes. The statements on this website have not been evaluated by the Food and Drug Administration.
